Jump to content

Proglumetacin: Difference between revisions

Page 1
Page 2
Content deleted Content added
CheMoBot (talk | contribs)
Updating {{drugbox}} (changes to verified fields - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:WikiProject_Pha
Changing short description from "Chemical compound" to "Non-steroidal anti-inflammatory drug"
 
(17 intermediate revisions by 14 users not shown)
Line 1: Line 1:
{{Short description|Non-steroidal anti-inflammatory drug}}
{{drugbox
{{Drugbox
| Verifiedfields = changed
| UNII_Ref = {{fdacite|changed|FDA}}
| Watchedfields = changed
| verifiedrevid = 443950501
| UNII = FV919079LU
| IUPAC_name = 3-<nowiki/>{4-[2-({[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1''H''-indol-3-yl]acetyl}oxy)ethyl]piperazin-1-yl}propyl ''N''<sup>2</sup>-benzoyl-''N,N''-dipropyl-α-glutaminate
| verifiedrevid = 400862995
| image = Proglumetacin.svg
| IUPAC_name = 3-{4-[2-({[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1''H''-indol-3-yl]acetyl}oxy)ethyl]piperazin-1-yl}propyl ''N''<sup>2</sup>-benzoyl-''N,N''-dipropyl-α-glutaminate

|synonyms = <small>3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate</small>
<!--Clinical data-->
| image = Proglumetacin.svg
| tradename =
| Drugs.com = {{drugs.com|international|proglumetacin}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism = [[Liver|Hepatic]]. Undergoes [[enterohepatic circulation|enterohepatic recirculation]]
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number = 57132-53-3
| CAS_supplemental = {{CAS|59209-40-4}}
| ATC_prefix = M01
| ATC_suffix = AB14
| PubChem = 4921
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4752
| ChemSpiderID = 4752
| ChEBI = 76263
| InChI = 1/C46H58ClN5O8/c1-5-21-51(22-6-2)46(57)40(48-44(55)34-11-8-7-9-12-34)18-20-42(53)59-29-10-23-49-24-26-50(27-25-49)28-30-60-43(54)32-38-33(3)52(41-19-17-37(58-4)31-39(38)41)45(56)35-13-15-36(47)16-14-35/h7-9,11-17,19,31,40H,5-6,10,18,20-30,32H2,1-4H3,(H,48,55)
| UNII_Ref = {{fdacite|correct|FDA}}
| InChIKey = PTXGHCGBYMQQIG-UHFFFAOYAO
| UNII = FV919079LU

<!--Chemical data-->
| C=46 | H=58 | Cl=1 | N=5 | O=8
| smiles = Clc1ccc(cc1)C(=O)n3c2ccc(OC)cc2c(c3C)CC(=O)OCCN4CCN(CC4)CCCOC(=O)CCC(C(=O)N(CCC)CCC)NC(=O)c5ccccc5
| smiles = Clc1ccc(cc1)C(=O)n3c2ccc(OC)cc2c(c3C)CC(=O)OCCN4CCN(CC4)CCCOC(=O)CCC(C(=O)N(CCC)CCC)NC(=O)c5ccccc5
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
Line 16: Line 47:
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PTXGHCGBYMQQIG-UHFFFAOYSA-N
| StdInChIKey = PTXGHCGBYMQQIG-UHFFFAOYSA-N
| synonyms = <small>3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate</small>
| CAS_number = 57132-53-3
| CAS_supplemental = {{CAS|59209-40-4}} ([[maleate]])
| ATC_prefix = M01
| ATC_suffix = AB14
| PubChem = 4921
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| C=46|H=58|Cl=1|N=5|O=8
| molecular_weight = 844.43442 g/mol
| bioavailability =
| protein_bound =
| metabolism = [[Liver|Hepatic]]. Undergoes [[enterohepatic circulation|enterohepatic recirculation]]
| elimination_half-life =
| excretion =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
}}
}}

'''Proglumetacin''' (usually as the [[maleate]] salt, trade names '''Afloxan''', '''Protaxon''' and '''Proxil''') is a [[non-steroidal anti-inflammatory drug]]. It is [[drug metabolism|metabolized]] in the body to [[indometacin]] and [[proglumide]],<ref>{{cite journal |author=Setnikar I, Arigoni R, Chisté R, Makovec F, Revel L |title=Plasma levels of proglumetacin and its metabolites after intravenous or oral administration in the dog |journal=Arzneimittel-Forschung |volume=37 |issue=6 |pages=698–702 |year=1987 |pmid=3663267 |doi=}}</ref> a drug with [[wikt:antisecretory|antisecretory]] effects that helps prevent injury to the stomach lining.
'''Proglumetacin''' (usually as the [[maleate]] salt, trade names '''Afloxan''', '''Protaxon''' and '''Proxil''') is a [[nonsteroidal anti-inflammatory drug]] (NSAID). It is [[drug metabolism|metabolized]] in the body to [[indometacin]] and [[proglumide]],<ref>{{cite journal |vauthors=Setnikar I, Arigoni R, Chisté R, Makovec F, Revel L |title=Plasma levels of proglumetacin and its metabolites after intravenous or oral administration in the dog |journal=Arzneimittel-Forschung |volume=37 |issue=6 |pages=698–702 |year=1987 |pmid=3663267 }}</ref> a drug with [[wikt:antisecretory|antisecretory]] effects that helps prevent injury to the stomach lining.


==References==
==References==
Line 46: Line 56:


{{Anti-inflammatory and antirheumatic products}}
{{Anti-inflammatory and antirheumatic products}}
{{Prostanoidergics}}
{{NSAIDs}}


[[Category:Non-steroidal anti-inflammatory drugs]]
[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Prodrugs]]
[[Category:Prodrugs]]
[[Category:Indoles]]
[[Category:Indole ethers at the benzene ring]]
[[Category:Amides]]
[[Category:Phenol ethers]]
[[Category:Piperazines]]
[[Category:Piperazines]]
[[Category:Carboxylate esters]]
[[Category:Carboxylate esters]]
Line 59: Line 67:


{{musculoskeletal-drug-stub}}
{{musculoskeletal-drug-stub}}

[[es:Proglumetacina]]
[[sr:Proglumetacin]]
[[vi:Proglumetacin]]